Research ArticleOpen AccessGoogle Scholar indexed
Low Level Determination of Genotoxic Impurity in Deferasirox Formulation
Department of Chemistry, Ramnarian Ruia College, Mumbai, India.
Department of Chemistry, Ramnarian Ruia College, Mumbai, India.
Department of Chemistry, Ramnarian Ruia College, Mumbai, India.
- 1 Department of Chemistry, Ramnarian Ruia College, Mumbai, India.
- 2 Department of Chemistry, Ramnarian Ruia College, Mumbai, India.
- 3 Department of Chemistry, Ramnarian Ruia College, Mumbai, India.
Journal of Analytical Sciences, Methods and Instrumentation·Volume 03 (2013)·Pages 179–183·Published 8 October 2013·DOI10.4236/jasmi.2013.34023
Copy link · social · email
Abstract
4-hydrazinobenzoic acid has been highlighted as one of the potential genotoxic impurities (PGIs). A sensitive HPLC method was developed and validated for the determination of 4-hydrazino benzoic acid in Deferasirox Tablet. HPLC method on Zorbax SB C18 column (250 × 4.6 mm i.d.), 5 μm, with UV Detector was used. The proposed method was cost effective, specific, linear, accurate, rugged and precise. The calibration curves showed good linearity over the concentration range of 0.5 μg/ml to 1.5 μg/ml with respect to the sample. The correlation coefficient was 0.999. Excellent recoveries of 102% were obtained at the level 0.5 μg/ml.
KeywordsDeferasiroxGenotoxic4-Hydrazinobenzoic AcidHPLC
- S. Glowienke, W. Frieauff, T. Allmendinger, H. Martus, W. Suter and L. Mueller, “Structure-Activity Considerations and in Vitro Approaches to Assess the Genotoxicity of 19 Methane-, Benzen and Toluenesulfonic Acid Esters,” Mutation Research/Genetic Toxicology and Environmental Mutagenesis, Vol. 581, No. 1-2, 2005, pp. 23-24. http://dx.doi.org/10.1016/j.mrgentox.2004.10.004
- “Guidelines on the Limits of Genotoxic Impurities CPMP/ SWP/ 5199/02,” The European Medicines Agency [EMEA], Committee for Medical Products for Human Use [CHMP].
- I. Colon and S. M. Richoll, “Determination of Methyl and Ethyl Esters of Methanesulfonic, Benzenesulfonic and P-Toluenesulfonic Acids in Active Pharmaceutical Ingredients by Solid-Phase Microextraction (SPME) Coupled to GC/SIM-MS,” Journal of Pharmaceutical and Biomedical Analysis, Vol. 39, No. 3-4, 2005, pp. 477-485. http://dx.doi.org/10.1016/j.jpba.2005.04.037
- H. G. Ramjit, M. M. Singh and A. B. Coddington, “Gas Chromatographic/Mass Spectrometric Analysis of Methyl Methanesulphonate and Ethyl Methanesulphonate in the Bismesylate Salt of DPI 201-106, a Positive Inotropic Agent for the Treatment of Heart Failure,” Journal of Mass Spectrometry, Vol. 31, No. 8, 1996, pp. 867-872. http://dx.doi.org/10.1002/(SICI)1096-9888(199608)31:8 3.0.CO;2-Q
- S. Harikrishna, K. Nagabhusana Reddy, Y. Suresh, M. Ramkrishna, M. Sarat, K. Kishore and C. Rambabu, “Low-level Determination of 4-Hydrazino BenzoicAcid in Drug Substance by High Performance Liquid Chromatography/Mass Spectrometry,” E-Journal of Chemistry, Vol. 7, No. 2, 2010, pp. 403-408. http://dx.doi.org/10.1155/2010/616494
- S. Steinhauser, U. Heinz, M. Bartholoma, T. Weyhermüller, H. Nick and K. Hegetschweiler, “Complex Formation of ICL670 and Related Ligands with FeIII and FeII,” European Journal of Inorganic Chemistry, Vol. 2004, No. 21, 2004, pp. 4177-4192. http://dx.doi.org/10.1002/ejic.200400363